Barchart & Kalshi Announce Partnership on Event Markets
The strategic partnership will integrate Kalshi markets, data and content throughout Barchart, giving you more information for decision-making.
/NVIDIA%20Corp%20logo%20on%20phone%20and%20AI%20chip-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
In the past 30 days, Tesla, Robinhood, and FedEx’s unusually active put options generated big income. Looking out 30 days, here’s how the three stocks can keep the income flowing.
Teva Pharmaceutical (TEVA) is trading at new 5-year highs. Shares are up more than 40% over the past year. The stock has strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. TEVA...
After years of range trading, NYMEX platinum futures broke out to the upside in 2025, more than doubling from the 2025 closing price. As the market heads into 2026, platinum could have room to rally if...
/Cisco%20Systems%2C%20Inc_%20magnified%20logo-by%20Pavel%20Kapysh%20via%20Shutterstock.jpg)
Cisco Systems generated strong free cash flow in Q3, and there is every indication that it will continue. But CSCO stock has been flat. Shorting out-of-the-money put options and buying in-the-money calls...
March Euro currency futures present a buying opportunity on more price strength.
While you can swing for the fences, by measuring the risk geometry of HOOD stock, you can improve your odds of success with a more realistic proposition.
/Amphenol%20Corp_%20logo%20on%20phone%20and%20stock%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Amphenol is expected to unveil its fiscal fourth-quarter earnings next month, and analysts project a high double-digit profit growth.
Apple has long been seen as an AI laggard. However, the stock could fit into portfolios of investors worried about an AI bubble.
/Textron%20Inc_%20logo%20on%20HQ%20building-by%20Wirestock%20Creators%20via%20Shutterstock.jpg)
Textron is all set to release its fiscal fourth-quarter earnings soon, and analysts project a double-digit earnings rise.
/Abbott%20Laboratories%20logo-by%20360b%20via%20Shutterstock.jpg)
Abbott Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a low double-digit profit growth.
